Paper10440397
Recurrence of autoimmune hepatitis after liver transplantation.
Milkiewicz P and 4 others. Transplantation, 1999. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Recurrence of autoimmune hepatitis after liver transplantation. Papers, record 10440397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10440397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis, Autoimmune | Major topic |
| Liver Transplantation | Major topic |
| Analysis of Variance | |
| Antibodies, Antinuclear | |
| Aspartate Aminotransferases | |
| Biopsy | |
| Female | |
| Graft Rejection | |
| Humans | |
| Male | |
| Recurrence | |
| Time Factors |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40230082 | Living donor liver transplantation for autoimmune hepatitis in identical monozygotic twins: a case report. | Clin Transplant Res | 2025 | https://conductscience.org/library/papers/40230082 | PubMed |
| 38416312 | Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. | Hepatol Int | 2024 | https://conductscience.org/library/papers/38416312 | PubMed |
| 37945160 | Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence. | Clin Liver Dis | 2024 | https://conductscience.org/library/papers/37945160 | PubMed |
| 36950491 | Post-Transplant Immunosuppression in Autoimmune Liver Disease. | J Clin Exp Hepatol | 2023 | https://conductscience.org/library/papers/36950491 | PubMed |
| 34949757 | MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34949757 | PubMed |
| 34830699 | Antibody-Mediated Rejection and Recurrent Primary Disease: Two Main Obstacles in Abdominal Kidney, Liver, and Pancreas Transplants. | J Clin Med | 2021 | https://conductscience.org/library/papers/34830699 | PubMed |
| 34131586 | HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation. | Transplant Direct | 2021 | https://conductscience.org/library/papers/34131586 | PubMed |
| 33942203 | The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. | Hepatol Int | 2021 | https://conductscience.org/library/papers/33942203 | PubMed |
| 32328366 | Type 2 Autoimmune Hepatitis in a Male Patient with a Rare Complication of Vasculitis. | Cureus | 2020 | https://conductscience.org/library/papers/32328366 | PubMed |
| 32301319 | Autoimmune Hepatitis: 2019 Update. | Gut Liver | 2020 | https://conductscience.org/library/papers/32301319 | PubMed |
| 31886312 | Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. | J Immunol Res | 2019 | https://conductscience.org/library/papers/31886312 | PubMed |
| 28364820 | Autoimmune Hepatitis in the Liver Transplant Graft. | Clin Liver Dis | 2017 | https://conductscience.org/library/papers/28364820 | PubMed |
| 27923369 | Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients. | BMC Complement Altern Med | 2016 | https://conductscience.org/library/papers/27923369 | PubMed |
| 26934884 | Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. | Gut Liver | 2016 | https://conductscience.org/library/papers/26934884 | PubMed |
| 26447505 | Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research. | Transplantation | 2016 | https://conductscience.org/library/papers/26447505 | PubMed |
| 25999245 | Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease. | Dig Dis Sci | 2015 | https://conductscience.org/library/papers/25999245 | PubMed |
| 25749982 | Autoimmune hepatitis. | Front Med | 2015 | https://conductscience.org/library/papers/25749982 | PubMed |
| 25674386 | Liver transplantation and autoimmune hepatitis. | Intractable Rare Dis Res | 2015 | https://conductscience.org/library/papers/25674386 | PubMed |
| 24367228 | Epidemiology and treatment of autoimmune hepatitis. | Hepat Med | 2012 | https://conductscience.org/library/papers/24367228 | PubMed |
| 23801865 | Role of international criteria in the diagnosis of autoimmune hepatitis. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23801865 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNFRSF25 | 8718 | PubTator's text mining | https://conductscience.org/library/genes/8718 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10440397
GET https://conductscience.org/api/papers/v1/10440397/cited_by?page=2